Efficacy and Safety of Privigen®in Patients With Chronic Inflammatory Demyelinating Polyneuropathy: Results of a Prospective, Single-Arm, Open-Label Phase III Study (The PRIMA Study)
Journal of the Peripheral Nervous System - United Kingdom
doi 10.1111/jns5.12017
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2013
Authors
Publisher
Wiley